Studies employing benzidine staining and analyses of cell surface markers glycophorin A (GPA) and CD71 indicated that wogonin promoted differentiation of K562, imatinib-resistant K562, and primary patient-derived CML cells. This evidence concerns the gene TFRC and chronic myelogenous leukemia, BCR-ABL1 positive.